These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9103207)

  • 41. A new topographic approach to the spread of breast cancer: the grid method.
    Noël P; Gerard JP; Mayer M; Bailly C; Blondet R; Bobin JY; Colon J; Deglise P
    Cancer; 1977 Aug; 40(2):924-7. PubMed ID: 890673
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The conservative treatment of early breast cancer. The 1st Annual Wendell G. Scott Memorial Lecture.
    Hayward J
    Cancer; 1974 Feb; 33(2):593-9. PubMed ID: 4812775
    [No Abstract]   [Full Text] [Related]  

  • 43. Breast cancer and earlier detection efforts. Realized and unrealized impact on stage.
    Farwell MF; Foster RS; Costanza MC
    Arch Surg; 1993 May; 128(5):510-3; discussion 513-4. PubMed ID: 8489384
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Breast screening: axillary lymph node status of interval cancers by interval year.
    Bucchi L; Puliti D; Ravaioli A; Cortesi L; De Lisi V; Falcini F; Ferretti S; Frigerio A; Mangone L; Petrella M; Petrucci C; Sassoli de Bianchi P; Traina A; Tumino R; Zanetti R; Zorzi M; Paci E
    Breast; 2008 Oct; 17(5):477-83. PubMed ID: 18455401
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of breast cancers diagnosed in screening patients in their 40s with and without family history of breast cancer in a community outpatient facility.
    Destounis SV; Arieno AL; Morgan RC; Cavanaugh D; Seifert PJ; Murphy PF; Somerville PA
    AJR Am J Roentgenol; 2014 Apr; 202(4):928-32. PubMed ID: 24660726
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The association of pathologic and mammographic characteristics of primary human breast cancers with "slow" and "fast" growth rates and with axillary lymph node metastases.
    Heuser LS; Spratt JS; Kuhns JG; Chang AF; Polk HC; Buchanan JB
    Cancer; 1984 Jan; 53(1):96-8. PubMed ID: 6690006
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Results of a mammographic and clinical screening in a health district (USSL) of Brescia, Italy.
    Filippini L; Braga M; Perna E; Bianchi AM; Bettoni C; Lucini L; Pezzola D; Pinelli D; Tonini G; Tonini G; Callea F
    Tumori; 1996; 82(5):430-6. PubMed ID: 9063517
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Current philosophy in treatment of primary cancer of the breast.
    Cady B
    Med Clin North Am; 1975 Mar; 59(2):285-92. PubMed ID: 1117765
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 57% decline in Rhode Island invasive breast cancer mortality between 1987 and 2017: mammography predominates in preventing mortality.
    Cady B; Fulton JP
    Breast Cancer Res Treat; 2020 Nov; 184(1):135-147. PubMed ID: 32779036
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patterns of axillary lymphadenopathy demonstrated by mammography: implications for the asymptomatic woman in a breast screening programme.
    Hunter JV; Hunter GJ; Tucker AK
    Clin Radiol; 1987 Sep; 38(5):515-7. PubMed ID: 3665348
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improving size, lymph node metastatic rate, breast conservation, and mortality of invasive breast cancer in Rhode Island women, a well-screened population.
    Coburn NG; Cady B; Fulton JP; Law C; Chung MA
    Breast Cancer Res Treat; 2012 Oct; 135(3):831-7. PubMed ID: 22933028
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Screening mammography reduces morbidity of breast cancer treatment.
    Leung JW
    AJR Am J Roentgenol; 2005 May; 184(5):1508-9. PubMed ID: 15855106
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Twenty-year follow-up of minimal breast cancer from the Breast Cancer Detection Demonstration Project.
    Lopez MJ; Smart CR
    Surg Oncol Clin N Am; 1997 Apr; 6(2):393-401. PubMed ID: 9115504
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The pathology of breast cancer detected by mass population screening.
    Patchefsky AS; Shaber GS; Schwartz GF; Feig SA; Nerlinger RE
    Cancer; 1977 Oct; 40(4):1659-70. PubMed ID: 907976
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Minimal breast cancer: a clinically meaningful term?
    Saccani Jotti G; Petit JY; Contesso G
    Semin Oncol; 1986 Dec; 13(4):384-92. PubMed ID: 3541210
    [No Abstract]   [Full Text] [Related]  

  • 56. Interval carcinomas of the breast: a group with intermediate outcome.
    Schroën AA; Wobbes T; van der Sluis RF
    J Surg Oncol; 1996 Nov; 63(3):141-4. PubMed ID: 8944056
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Survival in breast cancer diagnosed between mammographic screening examinations.
    Holmberg LH; Tabar L; Adami HO; Bergström R
    Lancet; 1986 Jul; 2(8497):27-30. PubMed ID: 2873324
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era.
    Toss A; Isca C; Venturelli M; Nasso C; Ficarra G; Bellelli V; Armocida C; Barbieri E; Cortesi L; Moscetti L; Piacentini F; Omarini C; Andreotti A; Gambini A; Battista R; Dominici M; Tazzioli G
    ESMO Open; 2021 Apr; 6(2):100055. PubMed ID: 33582382
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metamorphosis of breast cancer.
    Egan RL
    South Med J; 1978 Nov; 71(11):1325-30. PubMed ID: 715480
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of mammography screening as a predictor of survival in postmenopausal breast cancer patients.
    Anttinen J; Kautiainen H; Kuopio T
    Br J Cancer; 2006 Jan; 94(1):147-51. PubMed ID: 16333306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.